Life Sciences & Diagnostics

TM Capital has a long history advising Life Sciences & Diagnostics companies in a variety of types of transactions including strategic sales, majority recapitalizations and growth capital raises. Our expertise in the Life Sciences & Diagnostics category is wide ranging, spanning segments including the design, development and manufacturing of Molecular Reagents, Diagnostic Tests and Analytical Instrumentation, Remote Sample Collection, and new technologies facilitating personalized data-based healthcare decision-making and leveraging artificial intelligence to enhance diagnostic accuracy.

Please reach out to our Life Sciences & Diagnostics investment banking team if you would like to confidentially discuss market dynamics or a potential transaction regarding your business.

What clients are saying

At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction. TM Capital brought deep industry expertise and relationships to this assignment, and a sharp focus on achieving our objectives. Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.

Fasha Mahjoor

Founder & CEO, Neoteryx, LLC

Life Sciences & Diagnostics Thought Leadership

Life Sciences & Diagnostics

Each month our Healthcare monthly reviews the latest valuation, M&A trends and news across the sector.
Past Reports

Life Sciences & Diagnostics Senior Investment Banking Team

Michael S. Goldman

Managing Director
mgoldman@tmcapital.com
(212) 809-1419

James I. McLaren

Managing Director
jmclaren@tmcapital.com
(212) 809-1414

John A. Dean

Director
jdean@tmcapital.com
(404) 995-6234
Please reach out to our Life Sciences & Diagnostics investment banking team if you would like to confidentially discuss market dynamics or a potential transaction regarding your business.
Contact